NFE2L2 and multiple sclerosis: In a pre-clinical study investigating dimethyl fumarate, a substance for the treatment of multiple sclerosis, as therapy for ICH, Nrf2 was considered as a key factor involved in the protective effects of dimethyl fumarate on ICH (Zhao et al., 2015b).